Orange Book product · Generic (ANDA)
ETOPOSIDE
ETOPOSIDE
At a glance
Jul 17, 1995
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 17, 1995
31 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ETOPOSIDE
Strength
20MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 074290
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETOPOSIDE
- 2026AVOPEFBrand (NDA)
NDA 220200 · AVYXA HOLDINGS
- 1986VEPESIDBrand (NDA)
NDA 019557 · ONESOURCE SPECIALTY
- 1983VEPESIDBrand (NDA)
NDA 018768 · CORDEN PHARMA
- 2017ETOPOSIDEGeneric (ANDA)
ANDA 203507 · NATCO PHARMA USA
- 2017ETOPOSIDEGeneric (ANDA)
ANDA 204927 · NATCO PHARMA USA
- 2001ETOPOSIDEGeneric (ANDA)
ANDA 075635 · MYLAN
- 1998ETOPOSIDEGeneric (ANDA)
ANDA 074983 · FRESENIUS KABI USA
- 1998ETOPOSIDEGeneric (ANDA)
ANDA 074968 · WATSON LABS INC
- 1997ETOPOSIDEGeneric (ANDA)
ANDA 074813 · PIERRE FABRE
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074228 · WATSON LABS
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074529 · MEITHEAL
- 1996ETOPOSIDEGeneric (ANDA)
ANDA 074513 · ACCORD HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
